Epidermal growth factor activates Na+/H+ exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 7, 2009, Pages 1174-1181

  Coaxum, Sonya D ^a,b   Garnovskaya, Maria N ^a,b   Gooz, Monika ^a,b   Baldys, Aleksander ^a,b   Raymond, John R ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

AG1478; Cytosensor microphysiometer; ECAR; Phosphorylation

Indexed keywords

CALMODULIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUPHENAZINE; JANUS KINASE; MESSENGER RNA; SODIUM PROTON EXCHANGE PROTEIN 1;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; PODOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; CALMODULIN; CELL DIFFERENTIATION; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; JANUS KINASES; LUCIFERASES; PHOSPHORYLATION; PODOCYTES; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM-HYDROGEN ANTIPORTER; TRANSFECTION;

EID: 67649390829     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.03.006     Document Type: Article

References (50)

1. Nowak G., and Schnellmann R.G. Integrative effects of EGF on metabolism and proliferation in renal proximal tubular cells. Am. J. Physiol. 269 (1995) C1317-C1325
2. Schaudies R.P., Nonclercq D., Nelson L., Toubeau G., Zanen J., Heuson-Stiennon J.A., and Laurent G. Endogenous EGF as a potential renotrophic factor in ischemia-induced acute renal failure. Am. J. Physiol. 265 (1993) F425-F434
3. Terzi F., Burtin M., Hekmati M., Federici P., Grimber G., Briand P., and Friedlander G. Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J. Clin. Invest. 106 (2000) 225-234
4. Sakurai H., Tsukamoto T., Kjelsberg C.A., Cantley L.G., and Nigam S.K. EGF receptor ligands are a large fraction of in vitro branching morphogens secreted by embryonic kidney. Am. J. Physiol. 273 (1997) F463-F472
5. Fleck C., and Pertsch J. Epidermal growth factor (EGF) increases the renal amino acid transport capacity in amino acid loaded rats. Amino Acids 15 (1998) 307-320
6. Du J., and Wilson P.D. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am. J. Physiol. 269 (1995) C487-C495
7. Pugh J.L., Sweeney Jr. W.E., and Avner E.D. Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. Kidney Int. 47 (1995) 774-781
8. Sweeney Jr. W.E., Hamahira K., Sweeney J., Garcia-Gatrell M., Frost P., and Avner E.D. Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. Kidney Int. 64 (2003) 1310-1319
9. Torres V.E., Sweeney Jr. W.E., Wang X., Qian Q., Harris P.C., Frost P., and Avner E.D. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int. 64 (2003) 1573-1579
10. Pavenstadt H. Roles of the podocyte in glomerular function. Am. J. Physiol. Renal. Physiol. 278 (2000) F173-F179
11. Pavenstadt H., Kriz W., and Kretzler M. Cell biology of the glomerular podocyte. Physiol. Rev. 83 (2003) 253-307
12. Pagtalunan M.E., Miller P.L., Jumping-Eagle S., Nelson R.G., Myers B.D., Rennke H.G., Coplon N.S., Sun L., and Meyer T.W. Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 99 (1997) 342-348
13. Mundel P., and Reiser J. New aspects of podocyte cell biology. Kidney Blood Press Res. 20 (1997) 173-176
14. Kihara I., Tsuchida S., Yaoita E., Yamamoto T., Hara M., Yanagihara T., and Takada T. Podocyte detachment and epithelial cell reaction in focal segmental glomerulosclerosis with cellular variants. Kidney Int. Suppl. 63 (1997) S171-S176
15. Schwartz M.M. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis. Ren. Fail. 22 (2000) 663-684
16. Smoyer W.E., and Mundel P. Regulation of podocyte structure during the development of nephrotic syndrome. J. Mol. Med. 76 (1998) 172-183
17. Kreidberg J.A. Podocyte differentiation and glomerulogenesis. J. Am. Soc. Nephrol. 14 (2003) 806-814
18. Endlich K., Kriz W., and Witzgall R. Update in podocyte biology. Curr. Opin. Nephrol. Hypertens 10 (2001) 331-340
19. Tryggvason K., and Wartiovaara J. Molecular basis of glomerular permselectivity. Curr. Opin. Nephrol. Hypertens 10 (2001) 543-549
20. Somlo S., and Mundel P. Getting a foothold in nephrotic syndrome. Nat. Genet. 24 (2000) 333-335
21. Barisoni L., and Mundel P. Podocyte biology and the emerging understanding of podocyte diseases. Am. J. Nephrol. 23 (2003) 353-360
22. Eddy A.A., and Schnaper H.W. The nephrotic syndrome: from the simple to the complex. Semin. Nephrol. 18 (1998) 304-316
23. Shimamura T., and Morrison A.B. A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am. J. Pathol. 79 (1975) 95-106
24. Denker S.P., and Barber D.L. Ion transport proteins anchor and regulate the cytoskeleton. Curr. Opin. Cell Biol. 14 (2002) 214-220
25. + exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. J. Biol. Chem. 279 (2004) 26280-26286
26. Putney L.K., and Barber D.L. Na-H exchange-dependent increase in intracellular pH times G2/M entry and transition. J. Biol. Chem. 278 (2003) 44645-44649
27. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 14 (2000) 2185-2197
28. + exchangers. J. Pharmacol. Exp. Ther. 288 (1999) 620-626
29. + exchange by epidermal growth factor elevates intracellular pH in A431 cells. J. Biol. Chem. 258 (1983) 12644-12653
30. + exchanger, NHE-1, by phosphorylating a set of common sites. J. Biol. Chem. 266 (1991) 19166-19171
31. 2+/calmodulin. J. Biol. Chem. 276 (2001) 17339-17346
32. + exchange through Janus kinase 2 and calmodulin. J. Biol. Chem. 278 (2003) 16908-16915
33. 2+/calmodulin. Biochemistry 42 (2003) 7178-7187
34. Mundel P., Reiser J., Zuniga Mejia Borja A., Pavenstadt H., Davidson G.R., Kriz W., and Zeller R. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 236 (1997) 248-258
35. ia3. J. Biol. Chem. 272 (1997) 7770-7776
36. 1A receptor involves distinct signalling cascades. Biochem. J. 330 Pt 1 (1998) 489-495
37. + exchanger isoforms in mouse endometrial epithelium. Biol. Reprod. 68 (2003) 302-308
38. Lui K.E., Panchal A.S., Santhanagopal A., Dixon S.J., and Bernier S.M. Epidermal growth factor stimulates proton efflux from chondrocytic cells. J. Cell Physiol. 192 (2002) 102-112
39. + exchanger-1 in esophageal epithelial defense against acid-induced injury. Am. J. Physiol. Gastrointest. Liver. Physiol. 290 (2006) G665-G673
40. + exchanger (NHE-2). Biochim. Biophys. Acta 1150 (1993) 199-202
41. + exchanger isoform 1. Int. J. Biochem. Cell. Biol. 37 (2005) 33-37
42. + exchanger isoform 1 (NHE1) is a novel member of the calmodulin-binding proteins. Identification and characterization of calmodulin-binding sites. J. Biol. Chem. 269 (1994) 13703-13709
43. 2+ responsiveness to the apical isoform NHE3. J. Biol. Chem. 270 (1995) 26460-26465
44. De Frutos T., Martin-Nieto J., and Villalobo A. Phosphorylation of calmodulin by permeabilized fibroblasts overexpressing the human epidermal growth factor receptor. Biol. Chem. 378 (1997) 31-37
45. Benaim G., and Villalobo A. Calmodulin Phosphorylation. Eur. J. Biochem. 269 (2002) 3619-3631
46. Benaim G., Cervino V., and Villalobo A. Comparative phosphorylation of calmodulin from trypanosomatids and bovine brain by calmodulin-binding protein kinases. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 120 (1998) 57-65
47. Deb T.B., Su L., Wong L., Bonvini E., Wells A., David M., and Johnson G.R. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF. J. Biol. Chem. 276 (2001) 15554-15560
48. Dowlati A., Nethery D., and Kern J.A. Combined inhibition of epidermal growth factor receptor and JAK/STAT pathways results in greater growth inhibition in vitro than single agent therapy. Mol. Cancer Ther. 3 (2004) 459-463
49. Benguria A., Hernandez-Perera O., Martinez-Pastor M.T., Sacks D.B., and Villalobo A. Phosphorylation of calmodulin by the epidermal-growth-factor-receptor tyrosine kinase. Eur. J. Biochem. 224 (1994) 909-916
50. Martin-Nieto J., and Villalobo A. The human epidermal growth factor receptor contains a juxtamembrane calmodulin-binding site. Biochemistry 37 (1998) 227-236